$AVRO AVROBIO, Inc. Insider Trading
Get free email notifications about insider trading in AVROBIO, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AVROBIO, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in AVROBIO, Inc. for free.
CIK Number: 0001681087
IRS Number: 810710585
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: AVRO
Company Address: ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE 02139
Phone number: 617-914-8420
Former name: AvroBio, Inc., date of change: 2016-07-29
AVROBIO, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2021 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Buy | P | 11.71 | 2,000 | 23,420 | 2,000 | 0 to 2 K |
Feb 04 2021 | AVRO | AVROBIO, Inc. | MACKAY GEOFFREY | President & CEO | Option Exercise | A | 16.02 | 343,850 | 5,508,477 | 343,850 | |
Feb 04 2021 | AVRO | AVROBIO, Inc. | Avruch Steven | Chief Legal Officer | Option Exercise | A | 16.02 | 98,200 | 1,573,164 | 98,200 | |
Feb 04 2021 | AVRO | AVROBIO, Inc. | Petersen Deanna M | Chief Business Offi ... | Option Exercise | A | 16.02 | 86,600 | 1,387,332 | 86,600 | |
Feb 04 2021 | AVRO | AVROBIO, Inc. | Ostrowski Erik | Chief Financial Off ... | Option Exercise | A | 16.02 | 119,100 | 1,907,982 | 119,100 | |
Feb 02 2021 | AVRO | AVROBIO, Inc. | Escolar Diana | Chief Medical Offic ... | Option Exercise | A | 14.55 | 130,000 | 1,891,500 | 130,000 | |
Dec 28 2020 | AVRO | AVROBIO, Inc. | MACKAY GEOFFREY | President & CEO | Option Exercise | M | 0.41 | 100,000 | 41,320 | 142,013 | |
Dec 28 2020 | AVRO | AVROBIO, Inc. | MACKAY GEOFFREY | President & CEO | Buy | M | 0.41 | 100,000 | 41,320 | 245,123 | 145.1 K to 245.1 K (+68.91 %) |
Oct 21 2020 | AVRO | AVROBIO, Inc. | Farfel Gail M | Director | Option Exercise | A | 16.14 | 28,000 | 451,920 | 28,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | Booth Bruce | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | Donenberg Phillip B. | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | Jenkins Annalisa | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | CLARK IAN T | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | Vickers Philip J. | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 | |
Jun 05 2020 | AVRO | AVROBIO, Inc. | PAIGE CHRISTOPHER | Director | Option Exercise | A | 21.91 | 14,000 | 306,740 | 14,000 |